Bristol Myers partners with Microsoft for AI-driven lung cancer detection

Core Insights - Bristol Myers Squibb has signed an agreement with Microsoft to utilize the tech company's AI-enabled radiology platform for enhancing early detection of lung cancer [1] Company Summary - The collaboration aims to leverage advanced technology to improve diagnostic processes in oncology, specifically targeting lung cancer [1]